Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Franciska Erdő:

Search results

Items: 1 to 20 of 23

1.

ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors.

Safar Z, Kis E, Erdo F, Zolnerciks JK, Krajcsi P.

Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):313-328. doi: 10.1080/17425255.2019.1591373. Epub 2019 Mar 16. Review.

PMID:
30856014
2.

Evaluation of intranasal delivery route of drug administration for brain targeting.

Erdő F, Bors LA, Farkas D, Bajza Á, Gizurarson S.

Brain Res Bull. 2018 Oct;143:155-170. doi: 10.1016/j.brainresbull.2018.10.009. Epub 2018 Oct 25. Review.

3.

Age-dependent changes at the blood-brain barrier. A Comparative structural and functional study in young adult and middle aged rats.

Bors L, Tóth K, Tóth EZ, Bajza Á, Csorba A, Szigeti K, Máthé D, Perlaki G, Orsi G, Tóth GK, Erdő F.

Brain Res Bull. 2018 May;139:269-277. doi: 10.1016/j.brainresbull.2018.03.001. Epub 2018 Mar 6.

4.

[Caffeine: traditional and new therapeutic indications and use as a dermatological model drug].

Bors L, Bajza Á, Kocsis D, Erdő F.

Orv Hetil. 2018 Mar;159(10):384-390. doi: 10.1556/650.2018.30993. Review. Hungarian.

PMID:
29504423
5.

Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice.

Erdő F, Nagy I, Tóth B, Bui A, Molnár É, Tímár Z, Magnan R, Krajcsi P.

Brain Res Bull. 2017 Jun;132:232-236. doi: 10.1016/j.brainresbull.2017.06.013. Epub 2017 Jun 16.

PMID:
28629814
6.

[Function, aging and dysfunction of blood-brain barrier. Crossing the barrier].

Erdő F, Hutka B, Dénes L.

Orv Hetil. 2016 Dec;157(51):2019-2027. Review. Hungarian.

PMID:
27989227
7.

Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Erdő F, Denes L, de Lange E.

J Cereb Blood Flow Metab. 2017 Jan;37(1):4-24. Epub 2016 Nov 11. Review.

8.

Membrane Transporters in Physiological Barriers of Pharmacological Importance.

Nagy I, Tóth B, Gáborik Z, Erdo F, Krajcsi P.

Curr Pharm Des. 2016;22(35):5347-5372. Review.

PMID:
27464727
9.

Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review.

Erdő F, Hashimoto N, Karvaly G, Nakamichi N, Kato Y.

J Control Release. 2016 Jul 10;233:147-61. doi: 10.1016/j.jconrel.2016.05.035. Epub 2016 May 16. Review. No abstract available.

PMID:
27196741
10.

[Role of drug transporters in the central nervous system].

Erdő F, Temesszentandrási-Ambrus C, Beéry E.

Orv Hetil. 2016 Mar 6;157(10):370-8. doi: 10.1556/650.2016.30382. Review. Hungarian.

PMID:
26920327
11.

Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design.

Sáfár Z, Vaskó B, Ritchie TK, Imre G, Mogyorósi K, Erdő F, Rajnai Z, Fekete Z, Szerémy P, Muka L, Zolnerciks JK, Herédi-Szabó K, Ragueneau-Majlessi I, Krajcsi P.

Curr Drug Metab. 2016;17(5):430-55. Review.

PMID:
26728264
12.

The use of microdialysis techniques in mice to study P-gp function at the blood-brain barrier.

Sziráki I, Erdő F, Trampus P, Sike M, Molnár PM, Rajnai Z, Molnár J, Wilhelm I, Fazakas C, Kis E, Krizbai I, Krajcsi P.

J Biomol Screen. 2013 Apr;18(4):430-40. doi: 10.1177/1087057112468156. Epub 2012 Nov 29.

PMID:
23204072
13.

ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.

Beéry E, Rajnai Z, Abonyi T, Makai I, Bánsághi S, Erdő F, Sziráki I, Herédi-Szabó K, Kis E, Jani M, Márki-Zay J, Tóth GK, Krajcsi P.

Drug Metab Pharmacokinet. 2012;27(3):349-53. Epub 2011 Nov 29.

14.

Efflux transporters in the blood-brain interfaces--in vitro and in vivo methods and correlations.

Krajcsi P, Jani M, Tóth B, Erdo F, Kis E, Beéry E, Sziráki I.

Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):419-31. doi: 10.1517/17425255.2012.668184. Epub 2012 Mar 6. Review.

PMID:
22394316
15.

Verification of brain penetration of the unbound fraction of a novel HER2/EGFR dual kinase inhibitor (TAK-285) by microdialysis in rats.

Erdo F, Gordon J, Wu JT, Sziráki I.

Brain Res Bull. 2012 Mar 10;87(4-5):413-9. doi: 10.1016/j.brainresbull.2012.01.002. Epub 2012 Jan 9.

PMID:
22245027
16.

Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.

Sziráki I, Erdo F, Beéry E, Molnár PM, Fazakas C, Wilhelm I, Makai I, Kis E, Herédi-Szabó K, Abonyi T, Krizbai I, Tóth GK, Krajcsi P.

J Biomol Screen. 2011 Sep;16(8):886-94. doi: 10.1177/1087057111414896. Epub 2011 Aug 10.

PMID:
21832259
17.

[Animal models of cerebral ischemia--testing therapeutic strategies in vivo].

Erdô F, Hossmann KA.

Ideggyogy Sz. 2007 Sep 30;60(9-10):356-69. Review. Hungarian.

PMID:
17987730
18.
19.

Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study.

Erdo F, Berzsenyi P, Német L, Andrási F.

Brain Res Bull. 2006 Jan 15;68(4):269-76. Epub 2005 Sep 19.

PMID:
16377432
20.

The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.

Erdo F, Berzsenyi P, Andrási F.

Brain Res Bull. 2005 Jul 15;66(1):43-9. Epub 2005 Apr 21.

PMID:
15925143

Supplemental Content

Loading ...
Support Center